Deutsch
English
Русский

Universitätsklinikum Würzburg 

ZIM (Zentrum Innere Medizin)
Haus A3/A4 

Oberdürrbacherstr. 6

97080 Würzburg

ZOM / ZIM

Studien - Pilzinfektionen

CASPHYLAX –pilot: Prospective trial to evaluate pharmacokinetic , safety and efficacy of intermittent application of increased doses of caspofungin for antifungal prophylaxis in high risk patients.
Phase II,
IIT W. Heinz; Universitätsklinik Würzburg, ClinicalTrials.gov Identifier: NCT01318148

PO 5520: Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections
Phase II/III

WSA-CS-008: Open Label Study of Isavuconazole in the Treatment of Patients With Aspergillosis and Renal Impairment or of Patients With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Phase III

WSA-CS 003: Open Label Study of Isavuconazole in the Treatment of Patients With Aspergillosis and Renal Impairment or of Patients With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Phase III

WSA-CS 004: A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi
Phase III

WSA-CS 008: A Phase III, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 versus Caspofungin Followed by Voriconazole regimen in the Treatment of Candidemia and other invasive Candida Infections.
Phase III